Loading: 100%
ARRAY BIOPHARMA INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 209 (as per Q3 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker ARRYno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170481216
datesClosing price (adj.)
13.10.201712.36
11.10.201712.29
04.10.201712.38
27.09.201712.16
20.09.201711.60
13.09.201710.53
06.09.20179.86
30.08.20179.19
23.08.20179.55
16.08.20178.98
09.08.20178.66
02.08.20177.31
26.07.20177.77
19.07.20178.47
12.07.20178.24
05.07.20178.99
27.06.20178.47
20.06.20178.35
13.06.20177.84
06.06.20177.66
30.05.20177.86
23.05.20178.39
16.05.20178.26
09.05.20177.02
02.05.20177.38
25.04.20178.81
18.04.20177.93
11.04.20178.43
04.04.20178.81
28.03.20179.30
21.03.20179.13
14.03.201711.00
07.03.201711.63
28.02.201711.50
21.02.201710.88
14.02.201712.00
07.02.201710.53
31.01.201710.87
24.01.201711.07
17.01.201711.24
10.01.20179.75
03.01.20178.56
27.12.20168.79
19.12.20168.71
12.12.20168.72
05.12.20168.71
28.11.20167.88
21.11.20168.04
14.11.20166.91
07.11.20166.03
31.10.20165.70
24.10.20166.23
17.10.20166.45
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
12.36n/a
Market Capitalisation
in million USD
2,100n/a
Enterprise Value
in million USD
2,094n/a
Common Shares Outstanding
as per Mar 31, 2017
169,897,032n/a
Preferred Shares Outstanding
as per Mar 31, 2017
2,720n/a
Average Basic Shares Outstanding
TTM
156,384,000n/a
Average Diluted Shares Outstanding
TTM
156,384,000n/a
Index Membership
n/a
Business Summary
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 118n/a
Receivables 63n/a
Total Current Assets 188n/a
PP&E 6n/a
Total Assets 196n/a
Accounts Payable 16n/a
Current Debt 0n/a
Total Current Liabilities 59n/a
Long-Term Debt 112n/a
Total Liabilities 211n/a
Total Equity -15n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -14n/a
Operating Cash Flow -90n/a
Net Change in PP&E and Intangibles -3n/a
Investing Cash Flow -6n/a
Dividends Paid 0n/a
Financing Cash Flow 17n/a
Total Change in Cash -79n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value -0.01n/a
Other Ratios
Current Ratio 315.3%n/a
Liabilities to Equity Ratio -1,425.3%n/a
Debt to Assets Ratio 57.1%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
54
72
85
70
42
52
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-28
-29
-24
-30
-46
-44
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
26
43
61
40
-4
8
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-90
-80
-72
-79
-72
-86
Selling, General & Administrative
-17
-16
-15
-20
-22
-31
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-72
-63
-57
-59
-50
-54
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-64
-37
-11
-40
-76
-78
Non-Operating Income (Loss)
17
16
12
11
10
10
Interest Expense, net
17
16
12
11
10
10
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-47
-21
1
-28
-66
-68
Abnormal Gains (Losses)
-1
4
1
11
0
-98
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-49
-16
2
-17
-66
-166
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-49
-16
2
-17
-66
-166
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-49
-16
2
-17
-66
-166
Minority Interest
0
0
0
0
0
0
Net Income
-49
-16
2
-17
-66
-166
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-49
-16
2
-17
-66
-166
Remarks
restated on Aug 16, 2012 n/a
calculated values,
restated on Aug 12, 2013 n/a
calculated values,
restated on Aug 15, 2014 n/a
calculated values,
restated on Aug 21, 2015 n/a
calculated values,
restated on Aug 21, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 90% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
64
89
108
111
178
Cash & Cash Equivalents
n/a
48
56
61
69
56
Short Term Investments
n/a
16
33
48
42
123
Accounts & Notes Receivable
n/a
0
1
10
5
6
Accounts Receivable, Net
n/a
0
1
10
5
6
Notes Receivable, Net
n/a
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
Other Short Term Assets
n/a
6
3
3
5
6
Prepaid Expenses
n/a
6
3
3
5
6
Derivative & Hedging Assets
n/a
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
Total Current Assets
n/a
71
93
121
122
191
Property, Plant & Equipment, Net
n/a
16
12
10
8
5
Property, Plant & Equipment
n/a
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
Long Term Investments & Receivables
n/a
1
0
0
1
0
Long Term Investments
n/a
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
Other Long Term Assets
n/a
2
2
4
6
2
Intangible Assets
n/a
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
2
2
4
6
2
Total Noncurrent Assets
n/a
19
15
15
15
7
Total Assets
n/a
89
108
136
137
198
Liabilities and owners' equity
Payables & Accruals
n/a
18 18451000
21 20780000
22 21588000
27 26646000
32 32193000
Accounts Payable
n/a
4 4460000
6 6466000
5 5396000
7 6953000
5 4570000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
14 13991000
14 14314000
16 16192000
20 19693000
28 27623000
Short Term Debt
n/a
0 150000
0 150000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
51 51207000
55 55006000
29 28989000
26 26087000
10 10231000
Deferred Revenue
n/a
48 47874000
42 42339000
14 14353000
6 6193000
9 8946000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
3 3333000
13 12667000
15 14636000
20 19894000
1 1285000
Total Current Liabilities
n/a
70 69808000
76 75936000
51 50577000
53 52733000
42 42424000
Long Term Debt
n/a
91 91390000
92 92106000
99 99021000
102 101524000
107 107280000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
98 98419000
65 65222000
48 47684000
47 47474000
6 5850000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
39 39306000
13 13228000
0 0
3 3353000
2 2040000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
1 540000
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
59 58573000
52 51994000
48 47684000
44 44121000
4 3810000
Total Noncurrent Liabilities
n/a
190 189809000
157 157328000
147 146705000
149 148998000
113 113130000
Total Liabilities
n/a
260 259617000
233 233264000
197 197282000
202 201731000
156 155554000
Preferred Equity
n/a
0 0
8 8054000
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
347 346910000
437 437493000
571 571387000
653 652828000
751 751215000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-547 -547156000
-571 -570737000
-633 -632679000
-718 -717936000
-709 -708567000
Other Equity
n/a
0 3000
0 -1000
0 -2000
0 2000
0 5000
Equity Before Minority Interest
n/a
-200 -200243000
-125 -125191000
-61 -61294000
-65 -65106000
43 42653000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
-200 -200243000
-125 -125191000
-61 -61294000
-65 -65106000
43 42653000
Total Liabilities & Equity
n/a
59 59374000
108 108073000
136 135988000
137 136625000
198 198207000
Remarks restated on n/a restated on Aug 16, 2012 n/a restated on Aug 12, 2013 n/a restated on Aug 15, 2014 n/a restated on Aug 21, 2015 n/a restated on May 4, 2016 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-78
-56
-24
-62
-85
9
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
6
8
5
4
5
4
Non-Cash Items
13
18
10
22
5
-26
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
76
-35
-25
-51
4
7
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
18
-66
-34
-87
-72
-6
Change in Fixed Assets & Intangibles
-1
-2
-1
-2
-3
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
-68
76
-17
-14
5
-59
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
4
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-69
74
-19
-16
2
-58
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
40
0
-4
40
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
13
8
68
78
79
52
Increase in Capital Stock
13
8
68
78
79
52
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
-2
0
-4
-9
-2
-1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
51
7
60
108
77
51
Net Cash Before Disc. Operations and FX
0
15
8
5
8
-13
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
0
15
8
5
8
-13
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
0
15
8
5
8
-13
Remarks
restated on Aug 16, 2012 n/a
calculated values,
restated on Aug 12, 2013 n/a
calculated values,
restated on Aug 15, 2014 n/a
calculated values,
restated on Aug 21, 2015 n/a
calculated values,
restated on Aug 19, 2016 n/a
calculated values,
restated on Aug 19, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo